Lexology PRO | European Union, Global, Israel, etc. | 24 Mar 2023
Biden vetoes Republican-led moves to ban ESG factors in investment decisions, the EU proposes a Green Claims Directive, and ESG benchmark providers risk widespread failings – plus other key updates.
Harris Sliwoski LLP | USA | 29 Jun 2022
We often receive questions from ketamine clinics regarding who must obtain a DEA registration to dispense controlled substances. There are two…
Ius Laboris | USA | 28 Oct 2021
While employers in the US transport industry are acutely aware of the effects COVID-19 has imposed over the last 18 months, another phenomenon has…
Lexology PRO | Australia, Canada, European Union, etc. | 3 Jun 2021
An update on the state of play for the legalisation of medical and recreational cannabis use in key jurisdictions around the globe.
Cote Law PLLC | USA | 26 Jan 2021
The Washington Post reports that the Biden Administration is preparing to pull back recent Health and Human Services (HHS) guidance designed to expand…
Cote Law PLLC | USA | 3 Dec 2020
More than four years ago, the Comprehensive Addiction and Recovery Act of 2016 (“CARA”) was signed into law. CARA, among other things, includes…
Cote Law PLLC | USA | 30 Oct 2020
The Drug Enforcement Administration (DEA) published its long-awaited Notice of Proposed Rulemaking (NPRM) regarding suspicious orders of controlled…
Jackson Lewis PC | USA | 22 Apr 2019
DHS is apparently citing federal cannabis laws as grounds for denying citizenship. Further, USCIS announced on April 19 that the USCIS Policy Manual…
Dinsmore & Shohl LLP | USA | 12 Apr 2019
The U.S. Food and Drug Administration (FDA) recently announced new steps it is taking to determine a framework for lawful marketing of appropriate…
Morgan, Lewis & Bockius LLP | USA | 26 Mar 2019
The Drug Enforcement Administration (DEA) recently announced an enhancement to the Automation of Reports and Consolidated Orders System (ARCOS) to…